Frankfurt - Delayed Quote EUR
Abeona Therapeutics Inc. (PCJ.F)
4.5000
-0.1000
(-2.17%)
At close: 8:02:52 AM GMT+2
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 3.2M | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
SESHADRI VISHWAS Chief Executive Officer | Sale at price 4.78 per share. | Direct | 119,500 | Mar 31, 2025 |
ALVINO MARK J. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
CROMBEZ ERIC M.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
SILVERSTEIN CHRISTINE BERNI Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
ALLAND LEILA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
AMOROSO MICHAEL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
CHARLES FAITH L. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
WUCHTERL DONALD A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
ZEIHER BERNHARDT G Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
ALVINO MARK J. Director | Sale at price 5.38 per share. | Direct | 21,520 | Jan 29, 2025 |
VAZZANO JOSEPH WALTER Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 21, 2025 |
SESHADRI VISHWAS Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 21, 2025 |
O'MALLEY BRENDAN M General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 21, 2025 |
ALVINO MARK J. Director | Sale at price 5.10 per share. | Direct | 20,400 | Jan 21, 2025 |
ALVINO MARK J. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 26, 2024 |
SILVERSTEIN CHRISTINE BERNI Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 26, 2024 |
ALLAND LEILA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 26, 2024 |
AMOROSO MICHAEL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 26, 2024 |
CHARLES FAITH L. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 26, 2024 |
WUCHTERL DONALD A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 26, 2024 |
CROMBEZ ERIC M.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 13, 2024 |
ZEIHER BERNHARDT G Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 13, 2024 |
ALVINO MARK J. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 8, 2024 |
VAZZANO JOSEPH WALTER Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 8, 2024 |
SILVERSTEIN CHRISTINE BERNI Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 8, 2024 |
ALLAND LEILA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 8, 2024 |
AMOROSO MICHAEL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 8, 2024 |
CHARLES FAITH L. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 8, 2024 |
WUCHTERL DONALD A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 8, 2024 |
SESHADRI VISHWAS Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 8, 2024 |
O'MALLEY BRENDAN M General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 8, 2024 |
ALVINO MARK J. Director | Sale at price 4.51 per share. | Direct | 116,764 | Jun 18, 2024 |
SILVERSTEIN CHRISTINE BERNI Director | Sale at price 4.51 per share. | Direct | 116,453 | Jun 18, 2024 |
ALLAND LEILA Director | Purchase at price 4.71 per share. | Direct | 51,799 | May 16, 2024 |
CHARLES FAITH L. Director | Purchase at price 3.28 per share. | Direct | 24,764 | Apr 26, 2024 |
VAZZANO JOSEPH WALTER Chief Financial Officer | Purchase at price 3.14 per share. | Direct | 17,609 | Apr 25, 2024 |
SESHADRI VISHWAS Chief Executive Officer | Purchase at price 3.20 per share. | Direct | 32,000 | Apr 25, 2024 |
O'MALLEY BRENDAN M General Counsel | Purchase at price 3.24 per share. | Direct | 27,864 | Apr 25, 2024 |
SESHADRI VISHWAS Chief Executive Officer | Purchase at price 4.39 per share. | Direct | 87,800 | Feb 6, 2024 |
ALVINO MARK J. Director | Sale at price 5.11 per share. | Direct | 36,199 | Jan 17, 2024 |
SILVERSTEIN CHRISTINE BERNI Director | Sale at price 3.91 per share. | Direct | 24,721 | Sep 27, 2023 |
ALLAND LEILA Director | Sale at price 3.90 per share. | Direct | 28,270 | Sep 27, 2023 |
AMOROSO MICHAEL Director | Sale at price 3.91 per share. | Direct | 21,542 | Sep 27, 2023 |
CHARLES FAITH L. Director | Sale at price 3.96 per share. | Direct | 32,987 | Sep 27, 2023 |
ALVINO MARK J. Director | Sale at price 3.91 per share. | Direct | 24,724 | Sep 27, 2023 |
SESHADRI VISHWAS Chief Executive Officer | Purchase at price 4.07 per share. | Direct | 81,400 | Sep 27, 2023 |
AMOROSO MICHAEL Director | Sale at price 3.90 per share. | Direct | 1,275 | Sep 20, 2023 |
VAZZANO JOSEPH WALTER Chief Financial Officer | Purchase at price 3.70 - 3.82 per share. | Direct | 11,458 | Sep 19, 2023 |
O'MALLEY BRENDAN M General Counsel | Purchase at price 3.80 per share. | Direct | 11,400 | Sep 18, 2023 |
AMOROSO MICHAEL Director | Sale at price 4.45 per share. | Direct | 1,504 | Jun 20, 2023 |
Related Tickers
2BO.F Serina Therapeutics Inc. R
5.10
+10.87%
ZA71.F Larimar Therapeutics, Inc.
1.9400
-6.73%
2GH.F Merus N.V.
32.60
-10.44%
DRUG.CN Bright Minds Biosciences Inc.
47.48
0.00%
NEXI NexImmune, Inc.
0.0001
0.00%
SER Serina Therapeutics, Inc.
6.09
+5.36%
VALN Valneva SE
6.99
+1.75%
SION Sionna Therapeutics, Inc.
12.60
-3.74%
AARD Aardvark Therapeutics, Inc. Common Stock
8.22
-3.52%
KALV KalVista Pharmaceuticals, Inc.
12.88
+3.45%